BIOLASE, Inc. (BIOLQ)

OTCMKTS · Delayed Price · Currency is USD
0.0125
+0.0020 (19.05%)
Jun 25, 2025, 4:00 PM EDT
-79.51%
Market Cap 384.27K
Revenue (ttm) 46.03M
Net Income (ttm) -15.97M
Shares Out 36.60M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 75,976
Average Volume 46,994
Open 0.0105
Previous Close 0.0105
Day's Range 0.0105 - 0.0125
52-Week Range 0.0040 - 0.1350
Beta -0.04
RSI 55.97
Earnings Date Mar 21, 2025

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (s... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1984
Employees 157
Stock Exchange OTCMKTS
Ticker Symbol BIOLQ
Full Company Profile

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.

Financial Statements

News

There is no news available yet.